Boos Christopher John, Vincent Emma, Mellor Adrian, O'Hara John, Newman Caroline, Cruttenden Richard, Scott Phylip, Cooke Mark, Matu Jamie, Woods David Richard
1Department of Cardiology, Poole Hospital NHS Foundation trust, Poole, UNITED KINGDOM; 2Department of Postgraduate Medical Education, Bournemouth University, Bournemouth, UNITED KINGDOM; 3Research Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, Leeds, UNITED KINGDOM; 4Defence Medical Services, Lichfield, UNITED KINGDOM; 5Department of Anaesthetics, James Cook University Hospital, Middlesbrough, UNITED KINGDOM; 6Department of Medicine, Northumbria and Newcastle NHS Trusts, Wansbeck General and Royal Victoria Infirmary, Newcastle, UNITED KINGDOM; and 7Department of Academic Medicine, University of Newcastle, Newcastle upon Tyne, UNITED KINGDOM.
Med Sci Sports Exerc. 2017 Dec;49(12):2562-2569. doi: 10.1249/MSS.0000000000001384.
There is evidence suggesting that high altitude (HA) exposure leads to a fall in heart rate variability (HRV) that is linked to the development of acute mountain sickness (AMS). The effects of sex on changes in HRV at HA and its relationship to AMS are unknown.
HRV (5-min single-lead ECG) was measured in 63 healthy adults (41 men and 22 women) 18-56 yr of age at sea level (SL) and during a HA trek at 3619, 4600, and 5140 m, respectively. The main effects of altitude (SL, 3619 m, 4600 m, and 5140 m) and sex (men vs women) and their potential interaction were assessed using a factorial repeated-measures ANOVA. Logistic regression analyses were performed to assess the ability of HRV to predict AMS.
Men and women were of similar age (31.2 ± 9.3 vs 31.7 ± 7.5 yr), ethnicity, and body and mass index. There was main effect for altitude on heart rate, SD of normal-to-normal (NN) intervals (SDNN), root mean square of successive differences (RMSSD), number of pairs of successive NN differing by >50 ms (NN50), NN50/total number of NN, very low-frequency power, low-frequency (LF) power, high-frequency (HF) power, and total power (TP). The most consistent effect on post hoc analysis was reduction in these HRV measures between 3619 and 5140 m at HA. Heart rate was significantly lower and SDNN, RMSSD, LF power, HF power, and TP were higher in men compared with women at HA. There was no interaction between sex and altitude for any of the HRV indices measured. HRV was not predictive of AMS development.
Increasing HA leads to a reduction in HRV. Significant differences between men and women emerge at HA. HRV was not predictive of AMS.
有证据表明,暴露于高海拔地区(HA)会导致心率变异性(HRV)下降,这与急性高原病(AMS)的发生有关。性别对高海拔地区HRV变化的影响及其与AMS的关系尚不清楚。
对63名年龄在18 - 56岁的健康成年人(41名男性和22名女性)分别在海平面(SL)以及在海拔3619米、4600米和5140米的高海拔徒步旅行期间测量HRV(5分钟单导联心电图)。使用析因重复测量方差分析评估海拔(SL、3619米、4600米和5140米)和性别(男性与女性)的主要影响及其潜在相互作用。进行逻辑回归分析以评估HRV预测AMS的能力。
男性和女性在年龄(31.2±9.3岁对31.7±7.5岁)、种族以及身体质量指数方面相似。海拔对心率、正常到正常(NN)间期标准差(SDNN)、逐次差值均方根(RMSSD)、逐次NN差值大于50毫秒的对数(NN50)、NN50/NN总数、极低频功率、低频(LF)功率、高频(HF)功率和总功率(TP)有主要影响。事后分析中最一致的影响是在高海拔地区,这些HRV指标在3619米至5140米之间降低。在高海拔地区,男性的心率显著低于女性,而SDNN、RMSSD、LF功率、HF功率和TP则高于女性。所测量的任何HRV指标在性别和海拔之间均无相互作用。HRV不能预测AMS的发生。
海拔升高导致HRV降低。在高海拔地区,男性和女性之间出现显著差异。HRV不能预测AMS。